Institutional investors hold a majority ownership of INCY through the 93.69% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry. Last, during the quarter ended September 2017, these large investors purchased a net $4.8 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
MANNING & NAPIER ADVISORS LLC Bought 1.1 Million shares of Incyte Corp